Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs

Journal of Controlled Release

Volumn 108, Issue 2-3, 2005, Pages 362-374

  Salonen, J ^a   Laitinen, L ^b   Kaukonen, A M ^b   Tuura, J ^a   Bjorkqvist M ^a   Heikkila T ^a   Vaha Heikkila K ^a   Hirvonen, J ^b   Lehto, V P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Drug release; Microparticles; Porous silicon; Thermally carbonized silicon; Thermally oxidized silicon

Indexed keywords

CARBONIZATION; MESOPOROUS MATERIALS; ORGANIC SOLVENTS; PHYSIOLOGICAL MODELS; POROUS SILICON; THERMOOXIDATION;

DRUG RELEASE; MICROPARTICLES; THERMALLY CARBONIZED SILICON; THERMALLY OXIDIZED SILICON;

DRUG DOSAGE;

FUROSEMIDE; GRISEOFULVIN; IBUPROFEN; ORGANIC SOLVENT; PHENAZONE; RANITIDINE; SILICON;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; OXIDATION; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY;

ADMINISTRATION, ORAL; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; LIPIDS; NANOSTRUCTURES; PARTICLE SIZE; POROSITY; SILICON; SOLUBILITY; THERMOGRAVIMETRY;

EID: 27744566574     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.08.017     Document Type: Article

References (27)

1. R.S. Shawgo, A.C. Richards Greyson, Y. Li, and M.J. Cima BioMEMS for drug delivery Curr. Opin. Solid State Mater. Sci. 6 2002 329 334
2. C.M. Niemeyer C.A. Mirkin Nanobiotechnology. Concepts, Applications and Perspectives 2004 Wiley-VCH Darmstadt
3. J.T. Santini, M.J. Cima, and R. Langer A controlled release microchip Nature 397 1999 335 338
4. L. Leoni, and T.A. Desai Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations IEEE Trans. Biomed. Eng. 48 2001 1335 1341
5. A. Ahmed, C. Bonner, and T.A. Desai Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery J. Control. Release 81 2002 291 306
6. A. Foraker, R. Walczak, M. Cohen, T. Boiarski, C. Grove, and P. Swaan Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Coco-2 cell monolayer Pharm. Res. 20 2003 110 116
7. G. Cavallaro, P. Pierro, F.S. Palumbo, F. Testa, L. Pasqua, and R. Aiello Drug delivery devices based on mesoporous silicate Drug Deliv. 11 2004 41 46
8. A.L. Doadrio, E.M.B. Sousa, J.C. Doadrio, J. Pérez-Pariente, I. Izquierdo-Barba, and M. Vallet-Regi Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery J. Control. Release 97 2004 125 132
9. B. Muñoz, A. Rámila, J. Pérez-Pariente, I. Diaz, and M. Vallet-Regi MCM-41 organic modification as drug delivery rate regulator Chem. Mater. 15 2003 500 503
10. B.C. Hancock, and M. Parks What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 2000 397 404
11. I.R. Wilding In search of a single solution for complex molecules Scrip Mag. 2001 (May) 9 11
12. K.R Horspool, and C.A. Lipinski Advancing new drug delivery concepts to gain the lead Drug Deliv. Technol. 3 2003 34 46
13. J. Salonen, M. Björkqvist, E. Laine, and L. Niinistö Effects of fabrication parameters on porous p+-type silicon morphology Phys. Status Solidi, A Appl. Res. 182 2000 249 254
14. L.T. Canham Bioactive silicon structure fabrication through nanoetching techniques Adv. Mater. 7 1995 1033 1037
15. L.T. Canham, C.L. Reeves, J.P. Newey, M.R. Houlton, T.I. Cox, J.M. Buriak, and M.P. Stewart Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma Adv. Mater. 11 1999 1505 1507
16. J.-N. Chazalviel, and F. Ozaram Surface modification of porous silicon L.T. Canham Properties of porous silicon 1997 INSPEC London, UK
17. J.H. Song, and M.J. Sailor Chemical modification of crystalline porous silicon surfaces Comments Inorg. Chem. 21 1999 69 84
18. FDA Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System 2000 Food and drug administration Baltimore, MD www.fda.gov/cder/guidance/index.htm
19. J. Salonen, M. Björkqvist, E. Laine, and L. Niinistö Stabilization of porous silicon surface by thermal decomposition of acetylene Appl. Surf. Sci. 225 2004 389 394
20. J. Salonen, E. Laine, and L. Niinistö Thermal carbonization of porous silicon surface by acetylene J. Appl. Phys. 91 2002 456 461
21. V.-P. Lehto, K. Vähä-Heikkilä, J. Paski, and J. Salonen Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles J. Therm. Anal. Calorim. 80 2005 393 397
22. J. Salonen, J. Paski, K. Vähä-Heikkilä, T. Heikkilä, M. Björkqvist, and V.-P. Lehto Determination of drug load in porous silicon microparticles by calorimetry Phys. Status Solidi, A Appl. Res. 202 2005 1629 1633
23. J. Salonen, V.-P. Lehto, M. Björkqvist, E. Laine, and L. Niinistö Chemical stability studies of thermally-carbonized porous silicon Mater. Res. Soc. Symp. Proc. 638 2001 F14.19.1-6
24. J. Salonen, V.-P. Lehto, and E. Laine Thermal oxidation of free-standing porous silicon films Appl. Phys. Lett. 70 1997 637 639
25. M. Björkqvist, J. Salonen, E. Laine, and L. Niinistö Comparison of stabilizing treatments on porous silicon for sensor applications Phys. Status Solidi, A Appl. Res. 197 2003 374 377
26. M. Björkqvist, J. Paski, J. Salonen, V.-P. Lehto, Hysteresis reduction in thermally carbonized porous silicon humidity sensor, IEEE Sens. J. (in press).
27. C. Charnay, S. Bégu, C. Tourné-Péteilh, L. Nicole, D.A. Lerner, and J.M. Devoisselle Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property Eur. J. Pharm. Biopharm. 57 2004 533 540